Filareto A - Search Results

1

Pax3-induced expansion enables the genetic correction of dystrophic satellite cells.

Filareto A, Rinaldi F, Arpke RW, Darabi R, Belanto JJ, Toso EA, Miller AZ, Ervasti JM, McIvor RS, Kyba M, Perlingeiro RC. Filareto A, et al. Skelet Muscle. 2015 Oct 26;5:36. doi: 10.1186/s13395-015-0061-7. eCollection 2015. Skelet Muscle. 2015. PMID: 26504514 Free PMC article.

2

Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors.

Darabi R, Santos FN, Filareto A, Pan W, Koene R, Rudnicki MA, Kyba M, Perlingeiro RC. Darabi R, et al. Among authors: filareto a. Stem Cells. 2011 May;29(5):777-90. doi: 10.1002/stem.625. Stem Cells. 2011. PMID: 21374762 Free PMC article.

3

An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells.

Filareto A, Parker S, Darabi R, Borges L, Iacovino M, Schaaf T, Mayerhofer T, Chamberlain JS, Ervasti JM, McIvor RS, Kyba M, Perlingeiro RC. Filareto A, et al. Nat Commun. 2013;4:1549. doi: 10.1038/ncomms2550. Nat Commun. 2013. PMID: 23462992 Free PMC article.

4

Engraftment of ES-Derived Myogenic Progenitors in a Severe Mouse Model of Muscular Dystrophy.

Filareto A, Darabi R, Perlingeiro RC. Filareto A, et al. J Stem Cell Res Ther. 2012 Jan 6;10(1):S10-001. doi: 10.4172/2157-7633.S10-001. J Stem Cell Res Ther. 2012. PMID: 23483458 Free PMC article.

5

Skeletal Muscle Stem Cells from PSC-Derived Teratomas Have Functional Regenerative Capacity.

Chan SS, Arpke RW, Filareto A, Xie N, Pappas MP, Penaloza JS, Perlingeiro RCR, Kyba M. Chan SS, et al. Among authors: filareto a. Cell Stem Cell. 2018 Jul 5;23(1):74-85.e6. doi: 10.1016/j.stem.2018.06.010. Cell Stem Cell. 2018. PMID: 29979993 Free PMC article.

6

Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo.

Houang EM, Haman KJ, Filareto A, Perlingeiro RC, Bates FS, Lowe DA, Metzger JM. Houang EM, et al. Among authors: filareto a. Mol Ther Methods Clin Dev. 2015 Nov 11;2:15042. doi: 10.1038/mtm.2015.42. eCollection 2015. Mol Ther Methods Clin Dev. 2015. PMID: 26623440 Free PMC article.

7

Monitoring disease activity noninvasively in the mdx model of Duchenne muscular dystrophy.

Filareto A, Maguire-Nguyen K, Gan Q, Aldanondo G, Machado L, Chamberlain JS, Rando TA. Filareto A, et al. Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):7741-7746. doi: 10.1073/pnas.1802425115. Epub 2018 Jul 9. Proc Natl Acad Sci U S A. 2018. PMID: 29987034 Free PMC article.

8

Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy.

Ho PP, Lahey LJ, Mourkioti F, Kraft PE, Filareto A, Brandt M, Magnusson KEG, Finn EE, Chamberlain JS, Robinson WH, Blau HM, Steinman L. Ho PP, et al. Among authors: filareto a. Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):E9182-E9191. doi: 10.1073/pnas.1808648115. Epub 2018 Sep 4. Proc Natl Acad Sci U S A. 2018. PMID: 30181272 Free PMC article.

9

Stem cell therapy for muscular dystrophies.

Biressi S, Filareto A, Rando TA. Biressi S, et al. Among authors: filareto a. J Clin Invest. 2020 Nov 2;130(11):5652-5664. doi: 10.1172/JCI142031. J Clin Invest. 2020. PMID: 32946430 Free PMC article. Review.

10

Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy.

Lin BL, Shin JY, Jeffreys WP, Wang N, Lukban CA, Moorer MC, Velarde E, Hanselman OA, Kwon S, Kannan S, Riddle RC, Ward CW, Pullen SS, Filareto A, Kass DA. Lin BL, et al. Among authors: filareto a. JCI Insight. 2022 Oct 10;7(19):e158906. doi: 10.1172/jci.insight.158906. JCI Insight. 2022. PMID: 36099033 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page